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Background: The 2006 Centers for Disease Control and Prevention (CDC) revised recommendations for HIV testing
in clinical settings contained seven specific changes to how health care facilities should provide HIV testing. These
seven elements have been both supported and challenged in the lay and medical literature. Our first paper in BMC
Medical Ethics presented an analysis of the three HIV testing procedural changes included in the recommendations.
In this paper, we address the four remaining elements that concern HIV screening policy changes: (1) nontargeted
HIV screening, (2) making HIV screening similar to screening for other treatable conditions, (3) increasing HIV
screening without assured additional funding for linkage to care, and (4) making patients bear the costs of
increased HIV screening in health care settings.
Methods: We interviewed 25 members from the fields of US HIV advocacy, care, policy, and research about the
ethical merits and demerits of the four changes to HIV screening policies. We performed a qualitative analysis of
the participant responses in the interviews and summarized the major themes.
Results: Participants commented that nontargeted HIV screening and making HIV screening similar to screening
for other treatable medical conditions was ethical when it broadened the scope of people being tested for HIV.
However, they believed it was unethical when it did not respect the exceptional nature of HIV and HIV testing.
Some participants favored more testing regardless if there was assured additional funding for linkage to care or
if patients might bear the costs of testing because they believed that merely alerting patients of their status was
beneficial and would lead to positive consequences. Other participants found ethical flaws with testing without
assured linkage to care and patients bearing the costs of testing, as this could discriminate against those who
could not pay.
Conclusions: Our findings suggest that there are fundamental ethical disagreements that shape views on CDC’s
recommended HIV testing policies. Differences remain on whether or not HIV remains an exceptional condition
that requires it to be treated differently than other treatable conditions. Disagreement also exists on the
responsibilities of health care providers and rights of patients in regards to screening in (1) the absence of assured
linkage to care after an HIV diagnosis and (2) paying for the costs of HIV screening. Resolution of these
disagreements is needed to serve the common goal of using testing to facilitate medical care for those who are
HIV infected and for reducing HIV transmission.* Correspondence: mwaxman@hotmail.com
1Department of Emergency Medicine, Albany Medical College, Albany, USA
Full list of author information is available at the end of the article
© 2013 Waxman et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Waxman et al. BMC Medical Ethics 2013, 14:46 Page 2 of 13
http://www.biomedcentral.com/1472-6939/14/46Background
In September 2006, the Centers for Disease Control and
Prevention (CDC) proffered their revised recommenda-
tions for HIV testing in health care settings [1]. Since
the release of these recommendations, there has been
much discussion in the lay, medical, and public health
literature as to whether these recommendations are
morally problematic [2-31]. Through a review of both
the CDC’s recommendations and the commentaries on
this topic in the lay and medical literature, we identified
seven major elements or changes, either explicit in the
recommendations themselves or implied by them, which
were viewed by some as potentially morally troublesome.
These changes were: (1) an opt-out approach to screen-
ing, (2) no separate signed consent for HIV testing, (3)
optional prevention counseling at the time of testing, (4)
nontargeted screening, (5) making HIV screening similar
to screening for other treatable conditions, (6) increasing
HIV screening without assured additional funding for
linkage to care, and (7) making patients bear the costs of
increased HIV screening in health care settings.
The first three of these recommendations – an opt-out
approach, no separate signed consent for HIV testing,
and optional prevention counseling at the time of
testing – called for changes in how health care providers
approach, consent, and counsel patients when testing for
HIV. The ethical issues surrounding these topics were
discussed in our previous article in BMJ Medical Ethics
entitled, Perspectives on the ethical concerns and justifi-
cations of the 2006 Centers for Disease Control and
Prevention HIV testing recommendations [32]. In this
manuscript we address the four remaining changes that
concern revised HIV testing policies: nontargeted HIV
screening, making HIV screening similar to screening
for other treatable medical conditions, increasing HIV
screening without assured additional funding for linkage
to care, and making patients bear the costs of increased
HIV screening in health care settings.
The objective of this research was to obtain a system-
atic, balanced, and in-depth evaluation of the CDC
recommendations from informed sources. In order to
accomplish this objective, we attempted to capture
the full breadth and complexities of the participants’
perspectives. Therefore, we conducted semi-structured,
qualitative interviews with academicians, members of
advocacy groups, clinicians, policymakers, and re-
searchers who had voiced their opinions in the media
and professional and lay literature in an attempt to con-
duct a systematic ethical analysis of the CDC recom-
mendations. First, we asked respondents to identify the
potential benefits and the possible risks or harms posed
by the revised HIV testing policies. Second, we asked
whether respondents viewed each policy recommenda-
tion as either fulfilling or violating moral responsibilitiesto patients. Third, we asked whether each policy recom-
mendation respected or a violated patient rights. By
using a qualitative methodology, we ensured that the
participants were allowed to describe any nuances of
their perspectives without any preconceived suggestions.
We provide an accounting of the predominant themes.
Our aim was to inform the continuing debate on the im-
plementation of the CDC HIV testing recommendations
for the health care setting.
Methods
Study design
This manuscript reports on a qualitative analysis of re-
sponses to semi-structured interviews with 25 members
from the following fields: US HIV advocacy, clinical or
social care, policy, or research. Each individual had
commented on the 2006 CDC HIV testing recommen-
dations in the media or lay or professional literature.
The methods described for this manuscript are similar
to those reported in our previous paper [32], except as
noted here. The Rhode Island Hospital Institutional
Review Board approved this study.
Study population
In August 2007, we performed a search of MEDLINE,
Philosopher’s Index, SocIndex, the internet, and medical
and public health journal websites for all articles,
commentaries, editorials, press releases, publications,
research, and statements about the 2006 CDC HIV test-
ing recommendations. From this search, 164 documents
or websites met this criterion. From these, 55 authors or
persons quoted were identified, and constituted the
group of potential study participants. US government
officials were excluded from participation because of a
potential for conflict of interest.
Based on their remarks, the 55 potential study partici-
pants were categorized as either critics (or at least
voicing concerns) or supporters of the CDC’s recom-
mendations. These two groups were then subdivided by
respondent occupation. This sorting yielded five strata of
participants: supportive advocates (n = 11), concerned
advocates (n = 11), supportive academicians/clinicians/
researchers (n = 15), concerned academicians/clinicians/
researchers (n = 9), and local or state government
(non-federal) officials (n = 9). Using these strata, a list of
potential participants was generated.
In accordance with recommendations for conducting
qualitative research [33-35], we chose an a priori sample
size of 25 participants (five participants for each of the
five strata). A research assistant, who was not involved
in the interviewing process, contacted potential partici-
pants by email, letter, and telephone and invited them to
participate in a telephone interview. When extending
the invitations to potential participants, the research
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geographically-diverse participant sample. Invitations
were extended to potential participants until five persons
in each stratum were interviewed. No incentives were
provided to participants.
Protocol development
The study authors developed a protocol for the semi-
structured interviews. The semi-structured interview
design was chosen in order to allow participants to an-
swer the stated questions in a comprehensive fashion
and without preconceived biases. The protocol con-
tained questions germane to this analysis and included
the following HIV testing policy topics: (1) nontargeted
HIV screening, (2) making HIV screening similar to
screening for other treatable conditions, (3) increasing
HIV screening without assured additional funding for
linkage to care, and (4) making patients bear the costs of
increased HIV screening in health care settings. The
protocol contained open-ended questions that asked re-
spondents for their opinions on each the four policy
topics according to four ethical domains: (1) the benefits
of the change in HIV testing policy; (2) the risks or
harms of the change; (3) how the change in testing pol-
icy fulfills or violates ethical responsibilities of a health
care provider to administer appropriate medical care to
patients; and (4) how the change in testing policy re-
spects or violates patient rights. These four ethical do-
mains were chosen by our multidisciplinary group of
investigators (from the fields of clinical medicine, public
health, epidemiology, philosophy-bioethics, and survey
research methodology) and reflect the most common ap-
proaches to the ethical evaluation of policies: conse-
quentialist and rights approaches. Of the four familiar
principles of bioethics, beneficence and non-maleficence
are thought to be grounded in a consequentialist frame-
work, while duties to respect autonomy and duties of
justice are often associated with a rights-based approach
to morality [36].
Interview administration
The interview questions were part of a larger study that
gathered participants’ perspectives on the 2006 CDC
HIV testing recommendations, as described in our previ-
ous article. Prior to the telephone interviews, partici-
pants received a copy of the 2006 CDC HIV testing
recommendations and a brief synopsis of the study and
study topics. Two of the study authors [MJW and RCM]
conducted the interviews with each person performing
approximately half of the interviews. The interviewers
were blinded to participant strata and participants’ pre-
vious comments in the lay and medical literature. All in-
terviews were conducted via telephone from October
2007 through August 2008.At the start of each interview, each participant was
provided with a description of the nature of the study,
the topics under discussion, the questions that would be
asked, and definitions of any terms used in the inter-
views. Interviewers quoted the relevant CDC HIV test-
ing recommendation prior to initiating a discussion
about that HIV testing policy topic. Participants were
asked to confine their responses to ethical consider-
ations about each HIV testing policy, as opposed to the
practical implementation of the policy. Participants were
prompted as necessary to focus their answers on the
specific policy recommendation under discussion, and
reminded to avoid commenting on the remaining HIV
testing methods, policies, or the recommendations as a
whole. Participants giving short answers to the questions
were prompted to elaborate. Interviewers did not other-
wise provide any commentary or feedback to the partici-
pants. All interviews were audio-recorded and later
transcribed and de-identified by a research assistant who
was not involved in the interviews.
Analysis
A qualitative content analysis was performed on the de-
identified transcripts without regard to participant strata.
A quantitative analysis of the responses was not per-
formed, due to the sample size, methods of administra-
tion, purposive stratification of respondents, and goals of
the planned analysis. The transcribed responses were
reviewed and coded by the two interviewers. The two
interviewers identified themes, sub-themes, and sub-
sub-themes implicit in the participant responses. Two
secondary reviewers [MTC and MAC], who had not
conducted the interviewers, independently reviewed
separate random samples of 50% of the transcripts for
accuracy and thoroughness of the data extraction and
selection of themes, sub-themes, and sub-sub-themes.
Afterwards, the primary and secondary reviewers dis-




Benefits of nontargeted HIV screening
Respondents stated that making HIV screening nontar-
geted would identify more new infections. As one re-
spondent summarized this benefit, “it may capture more
undiagnosed individuals and offer them a chance to ac-
cess care at an early stage and (a chance) at prevention
services.” Per respondents, this benefit in turn leads to
positive downstream effects, including providing earlier
access to medical care and preventive services and –
through earlier diagnosis – better health outcomes and a
reduction in mortality. Second, nontargeted HIV screen-
ing broadens the population, setting, and scope of HIV
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broadening of the population also leads to positive
downstream effects, including providing greater educa-
tion about HIV and HIV testing. Third, nontargeted
HIV screening makes more people aware of their status,
which, in turn, leads to positive downstream effects such
as reducing future infections through changes in risk-
taking behavior for both infected and uninfected individ-
uals (Table 1).
Finally, respondents noted that nontargeted HIV screen-
ing improves efficiency and performance of screening
(by avoiding potential pitfalls of targeted screening, such
as providers incorrect assessments of risk or need for test-
ing); reduces patient barriers to testing; reduces the stigma
of HIV testing; and improves the structural framework
and health care system for HIV testing.
Risks or harms of nontargeted HIV screening
Five concerns emerged regarding the risks or harms as-
sociated with nontargeted screening. First, respondents
were concerned that testing might be conducted under
sub-optimal circumstances. Nontargeted HIV screening
might force patients to be tested when they are not
ready, or at inappropriate times. It might increase the
“psychotrauma” and emotional distress of testing itself,
increase the potential for physical or emotional harm
after testing (e.g. from domestic abuse), disallow
individualization of testing, and erode the physician pa-
tient relationship.
Second, nontargeted HIV screening may lead to poor
health care and financial resource utilization. Respon-
dents stated that unnecessarily screening large numbers
of people, particularly those with a low chance of being
HIV infected, would result in a low yield per test. In the
same light, when screening large numbers of people who
may not be at risk, there is an increased risk of false pos-
itives, which leads to emotional and financial distress
and erosion of the patient-physician relationship.
Third, nontargeted HIV screening has the potential to
be implemented in a cavalier fashion. As one respondent
commented, “People sort of relax their standards.”
Respondents were concerned that nontargeted HIV
screening ignores the need for population-specific HIV
screening procedures, such as fashioning different pro-
cesses for adolescents and other demographic groups. In
addition, clinicians might not review patient’s sexual
risks and behaviors at the time of the health care
interactions.
Fourth, there are negative downstream consequences
of increased testing as a result of nontargeted screening.
In particular, some respondents were concerned that
nontargeted screening would overburden the current
health care system with newly diagnosed people needing
treatment.Finally, nontargeted HIV screening places an increased
financial and emotional burden upon those who might
not truly require testing, and as a result, patients and
caregivers might resent or try to avoid HIV testing. Simi-
larly, some respondents were fearful that patients might
avoid health care all together if they thought they could
not seek medical attention without being tested.Fulfilling responsibilities to patients and respecting
patients’ rights with nontargeted HIV screening
Respondents perceived that nontargeted HIV screening
improves the general public health of the community by
improving the health of those individuals who are in-
fected. Further, it also improves the health of those
individuals who might have potentially been exposed be-
cause of the reduced transmission associated with more
people knowing their HIV status. Reasons cited for this
belief were that: nontargeted HIV screening increases
the likelihood that individuals will be tested for HIV; ob-
tains more information for patient’s about their health
and health needs; conducts necessary screening for
maintaining and promoting health; improves health care
outcomes through screening for a treatable condition;
identifies unrecognized HIV infections or risks for
infection; broadens screening to previously untested
populations; meets state-of-the-art medical care; and
destigmatizes HIV testing.Violating responsibilities to patients and patients’ rights
with nontargeted HIV screening
Some respondents were concerned that nontargeted
HIV screening could create conflicts with parents over
the testing of adolescents. They were also concerned
that nontargeted HIV screening increases costs and
emotional burdens because of unnecessary testing and
the increased likelihood of false positives. They were
concerned that nontargeted screening leads to an in-
crease in testing without a clear provision of how to
meet the needs of those who are found to be infected.
Finally, nontargeted HIV screening was perceived to
focus too much on public health, fail to individualize
care, and not provide for a patient-centered experience.
Some respondents commented that nontargeted HIV
screening could potentially violate responsibilities to
patients and patients’ rights if patient needs and readi-
ness were not assessed prior to testing, if proper in-
formed consent was not used, or if poor processes and
procedures were implemented. One respondent also
commented that the 2006 CDC recommendations for
nontargeted HIV screening did not include children
younger than 13- or adults older than 64-years-old, and,
therefore, did not address the health needs of these
populations.
Table 1 Themes of nontargeted HIV screening
Nontargeted HIV Screening
Benefits Risks or Harms
Theme: Identifies more new
infections
Theme: Tests under suboptimal
circumstances
Sub-theme: Leads to positive
downstream effects of identifying
new infections through increased
testing
Sub-theme: Forces patients to be
tested when not ready, or at
inappropriate times
Sub-subtheme: Provides earlier





access to preventive services
Sub-theme: Increases potential for
physical and psychological harm of
those tested
Sub-subtheme: Reduces mortality
and better health outcomes
because of earlier diagnosis
Sub-theme: Disallows
individualization of testing
Theme: Broadens the population,
setting, and scope of testing,
making testing more widely
available
Sub-subtheme: Causes erosion of
physician-patient relationship
Sub-theme: Leads to positive
downstream effects
Theme: Results in poor health care
and financial resource utilization
Sub-subtheme: Provides greater
education about HIV and HIV
testing
Sub-theme: Results in unnecessary
testing because of low yield
Theme: Makes more people aware
of their status
Sub-subtheme: Increases risk of




Sub-theme: Leads to positive
downstream effects
Sub-subtheme: Reduces future
infections through changes in risk-
taking behavior for those with
positive or negative HIV test results
Theme: Leads to potential for
cavalier implementation of testing
recommendations
Sub-theme: Ignores need for
population-specific HIV testing pro-
cedures, e.g., age-related, cultural
Sub-theme: Further reduces likeli-
hood that clinicians will review pa-
tient’s sexual risk
Theme: Improves efficiency and
performance of testing techniques
by clinical providers
Theme: Reduces patient barriers to
testing
Theme: Results in negative
downstream consequences of
increased testing
Theme: Reduces stigma of HIV
testing
Sub-theme: Overburdens health
care system with newly diagnosed
people needing treatment
Theme: Improves the structural
framework and health care system
for HIV testing
Theme: Creates resentment
towards testing by patients and
caregivers
Sub-theme: Results in patient
avoidance of health care
Theme: Increases financial and
emotional burden upon those who
might not truly require testing
How does nontargeted HIV
screening fulfill responsibilities to
patients?
How does nontargeted HIV
screening violate responsibilities
to patients?
Theme: Serves public health needs
Table 1 Themes of nontargeted HIV screening (Continued)
Theme: Increases testing without
clear provision of meeting needs
of those who are infected
Sub-theme: Provides public health
care needs of community
Theme: Creates conflicts with
parents over testing of
adolescents
Sub-theme: Positively impacts
health of individual though
reduced transmission
Theme: Increases costs and
emotional burdens because of
unnecessary testing and increased
likelihood of false positives
Theme: Obtains more information
about patient’s health and health
needs
Theme: Conducts necessary
screening for maintaining and
promoting health
Theme: Identifies unrecognized HIV
infections or risks for infection
Theme: Broadens screening to
previously untested populations
Theme: Destigmatizes HIV testing
How does nontargeted HIV
screening respect patients’ rights?
How does nontargeted HIV
screening violate patients’ rights?
Theme: Improves health care
outcomes through screening for a
treatable condition
Theme: Fails to individualize care
Sub-theme: Focuses on public
health care
Theme: Informs patient about their
health Sub-theme: Does not provide
patient-centered testing
experienceTheme: Expands testing to those
who might not have been tested
otherwise Theme: Increases testing without
clear provision of meeting needs
of those who are infectedTheme: Meets state-of-art medical
care
Theme: Increases likelihood
patients will be tested for HIV
Theme: Destigmatizes HIV testing
Theme: Identifies unrecognized HIV
infections
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HIV screening focuses more on the health care needs of
the society as a whole, instead of the individual. In this
light, nontargeted HIV screening neither fulfilled nor vi-
olated patients’ rights. In addition, one respondent com-
mented that nontargeted HIV screening involves an
avoidance of individual discussions with patients, which
underscores the tendency of clinicians to generally avoid
frank discussions about sex and sexuality with patients.Making HIV screening similar to screening for other
treatable medical conditions
Opinions about the recommendation to make HIV
screening similar to screening for other treatable condi-
tions were diverse. Some respondents viewed this rec-
ommendation as a positive change. They believed the
new policy would promote the view of HIV testing as
a routine part of maintaining health, eliminate HIV
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about risk for HIV and associated stereotypes. Others
viewed this recommendation negatively. They believed
HIV is a distinctly different disease that carries its own
stigma. In their opinion, these factors warrant that HIV
screening be treated differently from screening for other
treatable medical conditions. Other respondents thought
that HIV could be treated like other medical conditions,
but health care providers should remain respectful of
the disease/condition and its implications and unique-
ness. Still other respondents were concerned that mak-
ing HIV screening similar to screening for other
treatable medical diseases could lower testing standards,
or allow providers to order an HIV test without any
safeguards, which might not be optimal care for every-
one (Table 2).
Benefits of making HIV screening similar to screening for
other treatable medical conditions
One respondent summarized many of the benefits of
making HIV screening similar to screening for other
treatable medical conditions as, “I would say that the
major benefits are that it streamlines the process, it
really demystifies and to me really reduces or removes
the stigma of being tested, because it is just part of what
we do in providing medical care.” In general, respon-
dents thought that making HIV screening similar to
screening for other treatable medical conditions leads to
positive downstream affects. These positive downstream
effects include: identifying more HIV infections and
more people earlier in their infection; increasing testing
utilization; promoting a view of HIV as a treatable,
chronic condition; providing an understanding of the
true extent of the HIV epidemic; and improving public
health.
Second, making HIV screening similar to screening
for other treatable medical conditions facilitates the
HIV testing process and HIV testing in general. Respon-
dents cited that this change in policy: increases provider
comfort in offering testing and patient comfort in
accepting testing; encourages other medical/public
health groups to recommend routine HIV screening;
streamlines the HIV testing process for providers;
makes testing more convenient and accessible for pa-
tients; and leads to third-party insurers to pay for rou-
tine HIV screening.
Additionally, making HIV screening similar to screen-
ing for other treatable medical conditions promotes the
view of HIV testing as a routine part of maintaining
health; eliminates HIV exceptionalism; removes the as-
sumptions about risk for HIV and associated stereotypes;
normalizes HIV testing in comparison to other screening
tests; engenders belief that HIV screening is a part of
maintaining good health; destigmatizes HIV testing,reduces stigma about who is at risk for HIV, and changes
stereotypes about risk.Risks or harms of making HIV screening similar to
screening for other treatable medical conditions
The risks or harms of making HIV screening similar to
screening for other treatable medical conditions were di-
vided into several themes. First, making HIV screening
similar to screening for other treatable medical condi-
tions ignores the exceptional nature of HIV. As one re-
spondent commented, “I think it portrays a colossal
misunderstanding of what living with HIV is like … and
despite progress on the medical front and in the medical
management of HIV, there is still enormous stigma
around HIV and people have a really hard time grap-
pling with and assimilating the information and moving
forward.” Respondents commented that there is, in fact,
a persistence of stigma and adverse social and societal
problems with HIV. Making HIV screening similar to
screening for other treatable medical conditions under-
estimates the gravity of being diagnosed with HIV, falsely
equates HIV with other sexually transmitted diseases,
and downplays the significance of HIV in society.
In addition, making HIV screening similar to screening
for other treatable medical conditions: creates a potential
for poor or cavalier implementation of HIV testing rec-
ommendations; promotes screening by inadequately
prepared clinicians; encourages unneeded, superfluous
testing; fails to individualize screening; and creates con-
flicts in physician-patient relationships by potentially
having providers routinely order a test that patients do
not perceive as needed. One respondent also commen-
ted that many patients falsely presume that routine HIV
testing has been occurring all along.Fulfilling responsibilities to patients and respecting
patients’ rights by making HIV screening similar to
screening for other treatable medical conditions
Several themes emerged on how making HIV screening
similar to screening for other treatable medical condi-
tions might fulfill ethical obligations to patients and re-
spect patents’ rights. Making HIV screening similar to
screening for other treatable medical conditions leads to
a necessary screening for maintaining and promoting
health; incorporates a screening process into good,
standard clinical care; facilitates HIV testing; facilitates
harm and risk reduction to patients and their contacts;
identifies unrecognized HIV infections and facilitates
linkage to care of these patients; obtains more informa-
tion about patient’s health and health needs; leads to in-
creased testing, which has positive downstream effects;
and reduces stigma.
Table 2 Themes for making HIV screening similar to
screening for other treatable medical conditions
Making HIV screening similar to screening
for other treatable medical conditions
Benefits Risks or Harms
Theme: Destigmatizes HIV testing Theme: Ignores exceptional
nature of HIV
Sub-theme: Destigmatizes who is
at risk and removes stereotypes
about risk
Sub-theme: Leads to persistence
of stigma and adverse social,
societal problems
Theme: Leads to positive
downstream affects
Sub-theme: Underestimates
gravity of HIV diagnosis
Sub-theme: Identifies more HIV
infections
Sub-theme: Falsely equates HIV




significance of HIV in society
Sub-theme: Identifies people earlier
in infection Theme: Leads to potential for poor
or cavalier implementation of HIV
testing recommendationsSub-theme: Promotes view of HIV
as a treatable, chronic condition





understanding of the true extent of
the HIV epidemic
Theme: Fails to individualize
screening
Theme: Creates conflicts in
physician-patient relationshipsSub-theme: Improves public health
Theme: Facilitates HIV testing
Sub-theme: Increases provider
comfort in offering HIV screening
Sub-theme: Increases patient
comfort in being tested for HIV
Sub-theme: Encourages other
medical/public health groups to
recommend routine HIV screening
Sub-theme: May lead to third-party
insurers to pay for routine HIV
screening
Sub-theme: Streamlines HIV testing
process for providers
Sub-theme: Increases patient
comfort in being tested for HIV
Sub-theme: Makes testing more
convenient and accessible for
patients
Theme: Promotes view of HIV




Theme: Eliminates the assumptions
about risk for HIV and associated
stereotypes
Theme: Normalizes HIV testing in
comparison to other screening
tests
Table 2 Themes for making HIV screening similar to
screening for other treatable medical conditions
(Continued)
Theme: Engenders belief that HIV
screening is a part of maintaining
good health
How does making HIV screening
similar to screening for other
treatable medical conditions
fulfill responsibilities to patients?
How does making HIV screening





screening for maintaining and
promoting health
Theme: Violates obligation to
assess patient’s emotional health
and safety before testing
Theme: Obtains more information




Theme: Identifies unrecognized HIV
infections and facilitates linkage to
care
Theme: Facilitates HIV testing
Theme: Facilitates harm and risk
reduction to patients and their
contacts
How does making HIV screening
similar to screening for other
treatable medical conditions
respect patients’ rights?
How does making HIV screening
similar to screening for other
treatable medical conditions
violate patients’ rights?
Theme: Incorporates a process into
good, standard clinical care
Theme: Creates a potential for
poor or cavalier implementation of
HIV testing recommendations
Theme: Leads to increased testing,
which has positive downstream
effects
Theme: Reduces stigma
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by making HIV screening similar to screening for other
treatable medical conditions
Respondents perceived that making HIV screening simi-
lar to screening for other treatable medical conditions
might violate patients’ rights because it negates an obli-
gation to assess patients’ emotional health and safety be-
fore testing; ignores the exceptional nature of HIV; and
creates the potential for poor or cavalier implementation
of HIV testing recommendations.
Increasing HIV screening without assured additional
funding for linkage to care
There were a few premises and overarching themes that
pervaded much of the responses regarding increasing
HIV screening without assured additional funding for
linkage to care. Some respondents espoused the view,
summarized by one respondent, that “if you diagnose
HIV-infected individuals, additional money for linkage
to care will follow.” These respondents believed that ad-
vocacy could only start with testing and diagnosis. They
believed that if large numbers of HIV-infected individ-
uals are diagnosed, the health care system would adapt.
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as those with insurance or access to free HIV care –
would benefit from increased testing and diagnosis ef-
forts regardless of whether or not there was additional
funding for linkage to care. Respondents stated that
there is already screening for medical conditions other
than HIV (such as cancer) without assured linkage to
care, so HIV screening should not be an exception. An-
other premise was that the first obligation of clinical
providers is to diagnose, and that they should look for
treatment options afterwards. A final overarching theme
supporting HIV screening without additional funding for
linkage to care was that withholding knowledge of a pa-
tients HIV status was unethical given that testing tech-
nology was available (Table 3).
There were differences in how respondents viewed
whether the benefits of screening without assured
additional funding for linkage to care outweighed the
risks. Respondents who started with the premises
that (a) the ethical value of screening is to the indi-
vidual, and (b) there is an expectation for follow-up
care and treatment believed that this policy violates
patients’ rights when funding is not assured. On the
other hand, some respondents started with the prem-
ise that nontargeted screening can be justified by its
benefits to society alone. These respondents generally
viewed HIV screening without assured additional
funding for linkage to care as ethically appropriate
because it helped some individuals as well as society
as a whole.
Benefits of increasing HIV screening without assured
additional funding for linkage to care
The benefits associated with increasing HIV screening
without assured additional funding for linkage to care
were grouped into two main themes. First, increasing
HIV screening without assured additional funding for
linkage to care broadens the population, setting, and
scope of testing, thereby making testing more widely
available. Under this theme, there were two sub-themes.
First, increasing HIV screening without assured add-
itional funding for linkage to care identifies infections
earlier, which, in turn, helps promote better disease
management, informs patients of their health status, and
helps patients advocate for their health care needs. Fur-
thermore, more patients will ultimately receive treat-
ment because identifying more patients creates more
opportunities for advocacy efforts to improve access to
HIV services. As one respondent said, “I think that you
have to go forward anyways with the testing, because the
responsibility starts with people knowing their status.”
The second benefit theme was that increasing HIV
screening without assured additional funding for linkage
to care facilitates HIV prevention by (a) improvingpatient knowledge of their HIV status and (b) decreasing
HIV risk-taking behavior.
Risks or harms of increasing HIV screening without
assured additional funding for linkage to care
Some respondents perceived that screening without as-
sured funding for linkage to care adds to the burden of
an HIV diagnosis. The decoupling of diagnosis and link-
age to care would increase the social, physical, emo-
tional, psychological, and financial burdens of HIV. It
would increase stigma and discrimination associated
with HIV, further disenfranchise vulnerable people, and
increase opportunities for self-harm and self-destructive
behaviors. One respondent stated, “You’ve now added to
their own personal misery index.”
Second, respondents expressed worry that increasing
HIV screening without assured additional funding for
linkage to care emphasizes testing at the expense of
treatment. This emphasis, in turn, disenfranchises and
devalues populations who may benefit from testing but
do not have the resources to pay for treatment once they
are diagnosed. In addition, increasing testing without as-
sured additional funding for linkage to care potentially
floods HIV care clinics and lowers the quality of care of
all of those who are HIV-infected to meet the demand
of those who are newly diagnosed.
Third, increasing HIV screening without assured add-
itional funding for linkage to care establishes a lower
than ideal and potentially harmful level of care for those
with HIV. This lower standard ignores the complex
needs of HIV care and leads to poorer health outcomes
because of a lack of ability to afford care. Finally, testing
without assured linkage disincentivizes testing by pro-
viders and patients and overwhelms current HIV health
care and support resources.
Fulfilling responsibilities to patients and respecting
patients’ rights by increasing HIV screening without
assured additional funding for linkage to care
Respondents believed that increasing HIV screening
without assured additional funding for linkage to care
fulfills responsibilities to patients and respects patients’
rights because it fulfills an obligation by providers to
diagnose and inform patients about their health. In
addition, it empowers patients to take action to improve
their health; initiates a path to medical care; increases
advocacy for improved access to HIV care; and, eventu-
ally, leads to an expansion of resources for HIV care.
Violating responsibilities to patients and patients’ rights
by increasing HIV screening without assured additional
funding for linkage to care
Respondents perceived that increasing HIV screening
without assured additional funding for linkage to care
Table 3 Themes for increasing HIV screening without
assured additional funding for linkage to care
Increasing HIV screening without assured
additional funding for linkage to care
Benefits Risks or Harms
Theme: Broadens the population,
setting, and scope of testing,
making testing more widely
available
Theme: Adds to the burden of an
HIV diagnosis
Sub-theme: Further expands social,
physical, emotional, psychological,




Sub-theme: Increases stigma and
discrimination
Sub-subtheme: Informs patients of
their health care status
Sub-theme: Further expands social,
physical, emotional, psychological,
and financial burdens of HIV
Sub-subtheme: Helps patients





more patients to receive treatment
Sub-theme: Increases opportunities
for self-harm, self-destructive be-
haviors health
Sub-subtheme: Increases advocacy




Theme: Facilitates HIV prevention
Sub-theme: Decreases HIV risk-
taking behavior
Sub-theme: Improves patient





Sub-theme: Lowers quality of care
to meet demand of testing
Theme: Establishes a lower than
ideal and harmful level of care for
those with HIV
Sub-theme: Ignores complex needs
of HIV care
Sub-theme: Poorer health







Theme: Overwhelms current HIV
health care and support resources
How does increasing HIV
screening without assured
additional funding for linkage to
care fulfill responsibilities to
patients?
How does increasing HIV
screening without assured
additional funding for linkage to
care violate responsibilities to
patients?
Theme: Fulfills obligation to inform
patients about their health
Theme: Initiates path to medical
care
Theme: Incurs harm without
significant benefit
Table 3 Themes for increasing HIV screening without
assured additional funding for linkage to care (Continued)
Theme: Fulfills obligation to
diagnose
Theme: Is an inappropriate action
because testing when treatment
exists is not ethical
Theme: Manipulates people into
being tested under false pretenses
Theme: Promises hope of benefit
without clear intention of
treatment
Theme: Reduces quality of access
and care as resources are
overwhelmed
How does increasing HIV
screening without assured
additional funding for linkage to
care respect patients’ rights?
How does increasing HIV
screening without assured
additional funding for linkage to
care violate patients’ rights?
Theme: Informs patients about
their health
Theme: Violates right to receive
care for a treatable condition
Theme: Leads to an expansion of
resources for HIV care
Theme: Knowingly diagnoses early,
but induces harm because patients
will suffer without treatment
Theme: Empowers patients to take
action to improve their health
Theme: Violates benefit from
information about your health
Theme: Increases advocacy for
improved access to HIV care
Theme: Does not treat medical
care and testing on an equal basis
Theme: Violates purpose of testing
to lead to medical care and
benefits to patient
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because it lures people into being tested under false pre-
tenses and does them more harm than benefit. More-
over, it would promise the hope of benefit even though
there is no intent to treat. It would violate a patient’s right
to receive care for a treatable condition and to have infor-
mation about his or her health and to benefit from that in-
formation. It would defeat the purpose of testing, which is
to lead to medical care that benefits the patient. It is uneth-
ical to test for a treatable condition and withhold that treat-
ment; it does not treat medical care and testing on an equal
basis; and, reduces quality of access and care as resources
are overwhelmed by newly diagnosed individuals.
Making patients bear the costs of increased HIV screening
in health care settings
Most respondents believed that it would respect pa-
tients’ rights if they were to pay for the HIV test if they
had the means to do so; and it would violate patients’
rights to ask them to pay for the test if they did not have
the means to do so. Some respondents believed that the
cost of HIV testing was cheap when compared to the
alternative of not knowing one’s status. However, some
respondents acknowledged that this benefit might be
more pertinent for those who test positive than those
who test negative. Other respondents believed the costs
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HIV screening) that benefit society should be borne by
society (Table 4).
Benefits of making patients bear the costs of increased
HIV screening in health care settings
The benefits of making patients bear the costs of HIV
testing were that patients would learn their HIV status
and get treatment as needed. As one participant stated,
“knowledge is power.” This benefit is especially note-
worthy for patients who are diagnosed earlier than they
otherwise would have. Second, respondents perceivedTable 4 Themes for patients bearing the costs of
increased HIV screening in health care settings
Making patients bear the costs of increased
HIV screening in health care settings
Benefits Risks or Harms
Theme: Enables pPatients to learn
their HIV status and get treatment
as needed
Theme: Creates a barrier to testing
Sub-theme: Discriminates against
those least able to pay who need
testing mostTheme: Encourages patients to
“take ownership” of their behavior
and health needs Sub-theme: Leads to an avoidance
of testing because of costs
Theme: Serves as a motivator to
decrease risky behavior Sub-theme: Encourages self-
rationing of testing
Theme: Makes HIV screening
similar to screening for other
treatable conditions
Theme: Leads to question value of
HIV testing because of its costs
Theme: Forces people to pay for
something they might not want or
need
Theme: Uses testing as a source of
revenue instead of patient benefit
How does making patients bear
the costs of increased HIV
screening in health care settings
fulfill responsibilities to patients?
How does making patients bear
the costs of increased HIV
screening in health care settings
violate responsibilities to
patients?
Theme: Identifies patients needing
treatment




Theme: Enables public health
benefit of testing
Sub-theme: Decreases demand for
testing despite responsibility for
having patients tested
How does making patients bear
the costs of increased HIV
screening in health care settings
respect patients” rights?
How does making patients bear
the costs of increased HIV
screening in health care settings
violate patients’ rights?
Theme: Informs people about their
HIV status
Theme: Discriminates by economic
and class status
Theme: Enables autonomy of
choice in medical care
Theme: Obviates community-level
benefit of screening in society
Theme: Inhibits access to medical
services
Theme: Inhibits willingness to
undergo screeningthat patients paying for their own HIV test might
serve to make them think about their risk for HIV,
which could perhaps motivate them to reduce their risk-
taking behavior. Finally, respondents noted that making
patients bear the costs for their own screening tests in
fact makes HIV screening similar to other medical pro-
cedures for which patients are responsible.
Risks or harms of making patients bear the costs of
increased HIV screening in health care settings
Respondents highlighted two major risks or harms asso-
ciated with making patients bear the costs of increased
HIV screening. First, this creates a barrier to testing.
This barrier can exist because patients may decline test-
ing because they are unable to pay for the test. This con-
sequence was especially worrisome to some respondents
because they were concerned that those who cannot af-
ford testing or those who are dissuaded from testing be-
cause of its costs could be the same individuals who
need testing the most. Accordingly, if patients bear the
costs of testing, then they may self-ration testing and
test less frequently than needed. As one respondent
stated, “It violates (patients’ rights) to the extent that it
has an impact on the ability of those who need the ser-
vices to get them.”
Second, making patients bear the costs of testing
might lead to them to question the value of HIV testing
because of its costs. Other respondents also stated that
making patients bear the costs of HIV testing essentially
compells some individuals to pay for something they
might not want or need. This possibility was cited as
harmful, regardless of whether patients needed to pay
for the test themselves or through their insurance. Fi-
nally, it would be a waste of money for patients who
were at low risk of infection to bear the costs of HIV
testing and this would result in poor resource utilization.
Fulfilling responsibilities to patients and respecting
patients’ rights by making patients bear the costs of
increased HIV screening in health care settings
Respondents stated that charging patients for the cost of
HIV testing is consistent with caregiver responsibilities
to patients to test patients and demonstrates respect for
patients’ rights to know their HIV status. Since patients
can choose or refuse testing, patients are able to exercise
autonomy with regard to the medical care they receive.
Violating responsibilities to patients and patients’ rights
by making patients bear the costs of increased HIV
screening in health care settings
Respondents stated that making patients bear the costs
of HIV testing would violate responsibilities to patients
and violate patients’ rights because it would create a bar-
rier to good health care. This violation was especially
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such as vulnerable populations. In addition, having pa-
tients bear the costs of testing would decrease the de-
mand for testing, which some respondents believed was
a violation of patient rights.
Respondents also believed that making patients bear
the costs of HIV was potentially discriminative against
those without the ability to pay for access to information
and care. Further, by discouraging testing, this policy vi-
olated society’s rights to be protected against infectious
diseases.
Conclusions
When they first promulgated their recommendations in
2006, the stated goals of CDC were to increase the num-
ber of individuals who know their status and to destig-
matize HIV and HIV testing. Respondents disagreed on
whether or not implementation of the recommendations
would have these effects. Nontargeted HIV screening
and making HIV screening similar to screening for other
treatable medical conditions were often seen by respon-
dents as beneficial when these two recommended policy
changes were viewed as accomplishing the CDC goals of
increasing the number of patients tested and destigma-
tizing HIV testing and HIV. On the other hand, nontar-
geted HIV screening and treating HIV screening similar
to screening for similar treatable conditions were seen as
detrimental when they were perceived as potentially ig-
noring the exceptional nature of HIV and HIV testing,
and when they lead to “cavalier” testing. In order to rec-
oncile these conflicts, further research or attention
might be given to ensuring that when routine, nontar-
geted HIV screening is implemented, it is done so in a
fashion that ensures that patients are not tested without
their knowledge or permission. It is likely that these two
recommended policy changes would be viewed as ethical
if they increased the number of people tested without
leading to testing of individuals who were unaware of or
did not agree to testing.
Nontargeted HIV screening and making HIV screening
similar to screening for other treatable medical condi-
tions were also seen as detrimental if scarce resources
were wasted when perhaps more targeted approaches to
testing could instead be implemented. These findings
highlight the ongoing debate in terms of research
utilization between nontargeted and targeted testing
strategies. At least one study in an emergency depart-
ment setting has shown that targeted HIV screening
may find just as many new positive cases as nontargeted
testing while using fewer resources [37]. To add further
sophistication to the debate surrounding targeted vs.
nontargeted testing, it may be true that targeted testing
may save resources, and nontargeted testing may reduce
the stigma of HIV and HIV testing. While theimportance of these perhaps competing priorities has
not been determined, ongoing and future experience and
research will guide policy makers moving forward.
Finally, much of respondents discussion on nontar-
geted HIV screening and making HIV screening similar
to screening for other treatable medical conditions dis-
agreement highlighted the still present debate about
HIV exceptionalism, and whether HIV and HIV testing
should still be treated differently than other medical dis-
eases. Those respondents who viewed HIV testing as an
exceptional disease expressed opinions which generally
reflected a greater degree of individualization and pro-
tection of patients’ rights when approaching HIV testing,
while other respondents who believed that HIV was no
longer an exceptional disease, believed the 2006 CDC
HIV testing policies were in line with the destigmatiza-
tion of HIV and HIV testing. Over the last couple of
decades, with the advances in treatment and gradual
destigmatization of HIV, testing for HIV has become
more “routine.” Nevertheless, this topic remains quite
contentious and vocal advocates continue to argue both
for and against making HIV testing similar to screening
for other treatable medical conditions.
When analyzing participants’ responses on the topics
of increasing HIV screening without additional funding
for linkage to care and making patients bear the costs of
increased HIV screenings, we found that participants’
viewpoints often varied depending on their underlying
premises about HIV testing. Participants who approa-
ched HIV testing from the “knowledge is power” pos-
ition generally thought that HIV testing was a beneficial
intervention and should be performed regardless of
assured linkage to care or who would bear the costs. On
the other hand, participants who were more concerned
about the exceptional nature of HIV and HIV testing
were consequently defensive of patients’ individual
rights. While they agreed that HIV testing was, in gen-
eral, good, they also opined that HIV testing was a viola-
tion of patient autonomy or rights when patients were
tested for HIV without being provided the opportunity
for treatment. External funding for costs of testing and/
or linkage to care would mitigate the criticisms against
patients bearing the costs of testing and increasing HIV
testing without additional funding for linkage to care.
Finding ways to provide external funding – through pri-
vate, state, or federal grants, insurance coverage, or
other methods – might be a top priority for those
invested in scaling up testing [38]. It should be noted,
however, that these CDC recommendations for HIV
testing in clinical settings were published in September
2006. Since this time, the US Congress has passed the
Affordable Care Act and the United States Preventive
Services Task Force (USPSTF) has given HIV screening
a Grade A recommendation to HIV screening. The
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of individuals living in the US with health insurance.
And, the Grade A recommendation from the USPSTF
compels insurance companies to reimburse HIV screen-
ing. Therefore, compared to 2006, it is likely that fewer
patients overall will bear the costs of HIV testing in the
coming years. There are still issues yet to be determined,
however, such as how frequently HIV screening will be
reimbursed, how HIV testing will be reimbursed in the
context of bundled patient charges, etc.
Limitations
This qualitative analysis has several limitations. By their
nature, qualitative analyses do not necessarily weigh the
strengths of one participant’s argument against another,
or try to quantify how many respondents agreed with
one perspective or another. Therefore, this manuscript
does not attempt to conclude which viewpoints are more
valid or should be given more weight.
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